ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

Targeted ErbB4 receptor activation ameliorates neuronal deficits via DOCK3 signaling in a transgenic mouse AD model.

Chong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.